Five IPOs and three SPACs priced this week. Five IPO and two SPACs submitted filings. Signal processing platform HawkEye 360 (HAWK) priced at the top of the range to raise $416 million at a $2.8 billion market cap. HawkEye 360 is a defense technology...read more
Odyssey Therapeutics, a Phase 2 biotech developing precision therapies for autoimmune diseases, raised $279 million by offering 15.5 million shares at $18, the high end of the $16 to $18 range. The company originally filed to offer 13.2 million shares....read more
Odyssey Therapeutics, a Phase 2 biotech developing precision therapies for autoimmune diseases, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $225 million by offering 13.2 million shares at a price range of $16 to $18. ...read more
Updated Monday, 5/4. Five IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late. Radio signal analyzer HawkEye 360 (HAWK) plans to raise $400 million at a $2.7 billion market cap. HawkEye designs and operates...read more
US IPO Weekly Recap: Space intelligence provider HawkEye 350 leads 5 IPO week as pipeline grows
Five IPOs and three SPACs priced this week. Five IPO and two SPACs submitted filings. Signal processing platform HawkEye 360 (HAWK) priced at the top of the range to raise $416 million at a $2.8 billion market cap. HawkEye 360 is a defense technology...read more
Autoimmune diseases biotech Odyssey Therapeutics prices upsized IPO at $18, the high end of the range
Odyssey Therapeutics, a Phase 2 biotech developing precision therapies for autoimmune diseases, raised $279 million by offering 15.5 million shares at $18, the high end of the $16 to $18 range. The company originally filed to offer 13.2 million shares....read more
Autoimmune diseases biotech Odyssey Therapeutics sets terms for $225 million IPO, pricing this week
Odyssey Therapeutics, a Phase 2 biotech developing precision therapies for autoimmune diseases, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $225 million by offering 13.2 million shares at a price range of $16 to $18. ...read more
US IPO Week Ahead: May IPO market kicks off with defense tech, soft drinks, and more
Updated Monday, 5/4. Five IPOs are currently scheduled for the week ahead, though some smaller names may join the calendar late. Radio signal analyzer HawkEye 360 (HAWK) plans to raise $400 million at a $2.7 billion market cap. HawkEye designs and operates...read more